Gene · 6853
Papers3,694
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,694
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EFFECTS OF SHENFU INJECTION ON SUBLINGUAL MICROCIRCULATION IN SEPTIC SHOCK PATIENTS: A RANDOMIZED CONTROLLED TRIAL. | Shock | 2022 | 35959775 | PubTator, text mining | PubMed |
| Of Elephants and Other Mammals: A Comparative Review of Reproductive Tumors and Potential Impact on Conservation. | Animals (Basel) | 2022 | 35953994 | PubTator, text mining | PubMed |
| Extracellular vesicles and Alzheimer's disease in the novel era of Precision Medicine: implications for disease progression, diagnosis and treatment. | Exp Neurol | 2022 | 35952764 | PubTator, text mining | PubMed |
| A conformational switch controlling the toxicity of the prion protein. | Nat Struct Mol Biol | 2022 | 35948768 | PubTator, text mining | PubMed |
| Behavioural and functional evidence revealing the role of RBFOX1 variation in multiple psychiatric disorders and traits. | Mol Psychiatry | 2022 | 35948661 | PubTator, text mining | PubMed |
| Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson's disease patients. | NPJ Parkinsons Dis | 2022 | 35948563 | PubTator, text mining | PubMed |
| Raptor downregulation rescues neuronal phenotypes in mouse models of Tuberous Sclerosis Complex. | Nat Commun | 2022 | 35945201 | PubTator, text mining | PubMed |
| P301S-hTau acetylates KEAP1 to trigger synaptic toxicity via inhibiting NRF2/ARE pathway: A novel mechanism underlying hTau-induced synaptic toxicities. | Clin Transl Med | 2022 | 35917404 | PubTator, text mining | PubMed |
| The upregulation of glutamate decarboxylase 67 against hippocampal excitability damage in male fetal rats by prenatal caffeine exposure. | Environ Toxicol | 2022 | 35917217 | PubTator, text mining | PubMed |
| The Quest for Anti-α-Synuclein Antibody Specificity-Lessons Learnt From Flow Cytometry Analysis. | Front Neurol | 2022 | 35911883 | PubTator, text mining | PubMed |
| Brain-Derived Neurotrophic Factor and Extracellular Vesicle-Derived miRNAs in an Italian Cohort of Individuals With Obesity: A Key to Explain the Link Between Depression and Atherothrombosis. | Front Cardiovasc Med | 2022 | 35911513 | PubTator, text mining | PubMed |
| Neuroimaging in the Epileptic Baboon. | Front Vet Sci | 2022 | 35909685 | PubTator, text mining | PubMed |
| Optogenetic approaches to therapy for inherited retinal degenerations. | J Physiol | 2022 | 35908243 | PubTator, text mining | PubMed |
| Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases. | Int J Mol Sci | 2022 | 35897658 | PubTator, text mining | PubMed |
| Building a Network of Adverse Outcome Pathways (AOPs) Incorporating the Tau-Driven AOP Toward Memory Loss (AOP429). | J Alzheimers Dis Rep | 2022 | 35891639 | PubTator, text mining | PubMed |
| Power Line Communication and Sensing Using Time Series Forecasting. | Sensors (Basel) | 2022 | 35891000 | PubTator, text mining | PubMed |
| Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer's Disease. | Pharmaceutics | 2022 | 35890250 | PubTator, text mining | PubMed |
| Optogenetically Engineered Neurons Differentiated from Human SH-SY5Y Cells Survived and Expressed ChR2 in 3D Hydrogel. | Biomedicines | 2022 | 35884839 | PubTator, text mining | PubMed |
| Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics? | Biomolecules | 2022 | 35883513 | PubTator, text mining | PubMed |
| Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson's Disease. | Biomolecules | 2022 | 35883433 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6853/papers?page=36